Rotavirus virus-like particles (VLPs) and MS2 bacteriophages were bioaccumulated in bivalve mollusks to evaluate viral persistence in shellfish during depuration and relaying under natural conditions. Using this nonpathogenic surrogate virus, we were able to demonstrate that about 1 log10 of VLPs was depurated after 1 week in warm seawater (22 degrees C). Phage MS2 was depurated more rapidly (about 2 log10 in 1 week) than were VLPs, as determined using a single-compartment model and linear regression analysis. After being relayed in the estuary under the influence of the tides, VLPs were detected in oysters for up to 82 days following seeding with high levels of VLPs (concentration range between 10(10) and 10(9) particles per g of pancreatic tissue) and for 37 days for lower contamination levels (10(5) particles per g of pancreatic tissue). These data suggest that viral particles may persist in shellfish tissues for several weeks.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1265969 | PMC |
| http://dx.doi.org/10.1128/AEM.71.10.6049-6053.2005 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus.
Cell Biochem Funct
December 2024
Department of OS & OT, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Group A rotavirus (RVA) is a major cause of severe gastroenteritis in infants and young children globally, despite the availability of live-attenuated vaccines. Challenges such as limited efficacy in low-income regions, safety concerns for immunocompromised individuals, and cold-chain dependency necessitate alternative vaccine strategies. Subunit vaccines, which use specific viral proteins to elicit immunity, provide a safer and more adaptable approach.
View Article and Find Full Text PDFHuman norovirus disturbs intestinal motility and transit time through its capsid proteins.
PLoS Pathog
November 2024
KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Virus-Host Interactions & Therapeutic Approaches (VITA) Research Group, Leuven, Belgium.
Article Synopsis
- Human norovirus (HuNoV) causes over 700 million cases of gastroenteritis yearly, leading to symptoms like vomiting and diarrhea, but the mechanisms of infection are not well understood due to the absence of suitable animal models.
- Researchers utilized a zebrafish larvae model to investigate how HuNoV affects intestinal motility and whether a specific viral protein might act as an enterotoxin.
- The study found that HuNoV GII.4 infection increased intestinal contraction frequency and delayed food transit time in the larvae, indicating potential effects on bowel movements, with viral proteins VP1 and VP2 playing significant roles in these symptoms.
VP8 Mosaic Nanoparticles Elicit Cross-Neutralizing Immune Responses and Provide Protection Against Heterotypic Rotavirus Challenge in Mice.
ACS Nano
November 2024
State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Life Sciences, Xiamen University, Xiamen 361102, China.
Article Synopsis
- Group A rotaviruses (RVA) are a leading cause of diarrhea in children under 5, but vaccination has reduced instances and deaths.
- Recent challenges include decreasing efficacy of current rotavirus vaccines and new virus strains, highlighting the need for improved vaccines.
- This study explores using nanoparticles to enhance the immune response to rotavirus proteins, showing promise for developing a next-generation broad-spectrum vaccine.
Virus-like Particles vaccine based on co-expression of G5 Porcine rotavirus VP2-VP6-VP7 induces a powerful immune protective response in mice.
Vet Microbiol
November 2024
Key Laboratory of Bio-Resources and Eco-Environment, Ministry of Education, College of Life Science. Animal Disease Prevention and Food Safety Key Laboratory of Sichuan Province, Chengdu 610064, China. Electronic address:
Article Synopsis
- Porcine rotavirus (PoRV) is a major cause of severe diarrhea in young piglets, leading to high morbidity and mortality in the pig farming industry, with the G5 genotype being the most prevalent strain.
- Researchers developed a vaccine using an insect cell-baculovirus system that produced virus-like particles (VLPs) containing key rotavirus proteins (VP2, VP6, and VP7), resembling the natural rotavirus structure.
- Immunization trials in mice showed the VLPs effectively triggered strong immune responses and reduced PoRV levels, indicating their potential as an effective vaccine for preventing Porcine Rotavirus infections.
Production of norovirus-, rotavirus-, and enterovirus-like particles in insect cells is simplified by plasmid-based expression.
Sci Rep
June 2024
Virology and Vaccine Immunology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.
Insect cells have long been the main expression host of many virus-like particles (VLP). VLPs resemble the respective viruses but are non-infectious. They are important in vaccine development and serve as safe model systems in virus research.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!